Human embryonic stem cells from aneuploid blastocysts identified by pre-implantation genetic screening by Narwani, Kavita et al.
Human embryonic stem cells from aneuploid blastocysts
identified by pre-implantation genetic screening
Kavita Narwani & Juan-Carlos Biancotti &
Tamar Golan-Lev & Nicole Buehler & David Hill &
Sagiv Shifman & Nissim Benvenisty & Neta Lavon
Received: 31 March 2009 /Accepted: 19 January 2010 /Published online: 12 March 2010 / Editor: P. Andrews
# The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract Human embryonic stem cells are derived from the
inner cell mass of pre-implantation embryos. The cells have
unlimited proliferation potential and capacity to differentiate
into the cells of the three germ layers. Human embryonic stem
cells are used to study human embryogenesis and disease
modeling and may in the future serve as cells for cell therapy
and drug screening. Human embryonic stem cells are usually
isolated from surplus normal frozen embryos and were
suggested to be isolated from diseased embryos detected by
pre-implantation genetic diagnosis. Here we report the isolation
of 12 human embryonic stem cell lines and their thorough
characterization. The lines werederivedfrom embryos detected
to have aneuploidy by pre-implantation genetic screening.
Karyotype analysis of these cell lines showed that they are
euploid, having 46 chromosomes. Our interpretation is that the
euploid cells originated from mosaic embryos, and in vitro
selection favored the euploid cells. The undifferentiated cells
exhibitedlong-termproliferation and expressed markers typical
for embryonic stem cells such as OCT4, NANOG, and TRA-1-
60. The cells manifested pluripotent differentiation both in vivo
and in vitro. To further characterize the different lines, we have
analyzed their ethnic origin and the family relatedness among
them. The above results led us to conclude that the aneuploid
mosaic embryos that are destined to be discarded can serve as
source for normal euploid human embryonic stem cell lines.
These lines represent various ethnic groups; more lines are
needed to represent all populations.
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Introduction
Human embryonic stem cells (HESCs) are derived from the
inner cell mass (ICM) of pre-implantation embryos (Thomson
et al. 1998). HESCs have the unique properties of unlimited
proliferation potential and capacity to differentiate into the
cells comprising the entire human body (Itskovitz-Eldor et al.
2000; Schuldiner et al. 2000). The cells may serve as a
source of cells for cell therapy and drug screening. These
cells are also being used for the study of human embryo-
genesis and disease modeling.
HESCs are isolated from surplus embryos of in vitro
fertilization (IVF) treatments (Thomson et al. 1998; Reubinoff
et al. 2000). One common source of surplus normal embryos
is couples that have undergone IVF treatments and have
finished their family planning and have donated their frozen
blastocysts for research. Other sources of embryos for
research are poor-quality embryos, morula-stage embryos,
and single blastomeres (Mitalipova et al. 2003; Strelchenko
et al. 2004; Klimanskaya et al. 2007). Embryos carrying
genetic mutations detected by pre-implantation genetic diag-
nosis (PGD) or aneuploid embryos carrying abnormal
chromosomal number diagnosed by pre-implantation genetic
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The embryos going through PGD/PGS are commonly
biopsied at the eight-cell stage, corresponding to 3-d old
embryos. A hole is drilled in the zona pellucida (ZP), and one
or two of the blastomeres are removed for genetic analysis. By
the time the embryo reaches its blastocyst stage (5-d old
embryo), the healthy embryos are identified and separated,
and the abnormal embryos are either discarded or used for
research purposes. In PGD, the specific mutation that is
inherited in the family is usually analyzed by PCR (Ao et al.
1996). Among the genetic diseases that HESC lines were
derived from are Duchenne muscular dystrophy, Fanconi
anemia, and Fragile-X syndrome (Pickering et al. 2005;
Verlinsky et al. 2005; Eiges et al. 2007). PGS is widely
applied to identify chromosomal aneuploidies during IVF,
especially in cases of advanced maternal age. In PGS,
blastomeres are analyzed using single-cell fluorescent in situ
hybridization, which allows the analysis of chromosomes in
interphase cells using multicolor fluorescent probes for five to
12 chromosomes (Griffin et al. 1991). Embryos that are
detected as carrying chromosomal aneuploidies are destined to
be discarded unless donated for research. The widespread use
of PGS in some IVF clinics has created a new source of
surplus blastocyst-stage embryos that are available for the
establishment of HESC lines (Lavon et al. 2008).
We have previously shown that we can derive euploid
HESC lines, with normal karyotype, from blastocyst-stage
embryos that were diagnosed by PGS as aneuploid (Lavon
et al. 2008). Using polymorphic markers, we have shown
that the euploidy was not achieved through chromosomal
self correction. Instead, we have suggested that the euploid
HESC lines originated from mosaic embryos consisting of
aneuploid and euploid cells, and in vitro selection occurred
to favor euploid cells (Lavon et al. 2008). These results led
us to conclude that the aneuploid mosaic embryos that are
destined to be discarded can serve as an alternative source
for normal euploid HESC lines.
In this report, we summarize the data that we have
collected from the derivation of a dozen HESC lines,
carrying euploid karyotypes. The HESC lines exhibited
morphology and expressed markers typical of HESCs and
also demonstrated a capacity for long-term proliferation.
The derived HESC lines manifested pluripotent differenti-
ation both in vivo and in vitro. To further characterize the
HESC lines, we have analyzed their ethnic origin and the
family relatedness among them.
Materials and Methods
Derivation of HESCs from blastocysts after PGS. Isolation
of HESCs from blastocyst-stage embryos was performed under
the approvalof the StemCell ResearchOversight Committee at
Cedars-Sinai Medical Center, according to protocol #9647:
“Establishment of HESCs from Genetically Abnormal and
Spare IVF-Derived Embryos.” Blastocyst-stage embryos were
donated according to the informed consent under the approved
protocol. Blastocysts that did not completely hatch from the ZP
were either left over night to spontaneously hatch or were
assisted mechanically to release the blastocyst from the ZP
(Lavon et al. 2008). Thus, we have used 6- to 7-d-old naked
blastocysts for isolating the ICM. In most cases, the
trophectoderm (TE) was removed by immunosurgery (IS),
and a minority required mechanical dissection in order to
remove the TE layer from the ICM (Eiges et al. 2007). Using
a stripper, a naked blastocyst was transferred to a drop of anti-
human serum (Sigma, St. Louis, MO) diluted 1:5 with G2V3
blastocyst medium supplemented with human serum albumin
(Vitrolife, Englewood, CO) and incubated for 30 min at 37°C
in a 5% CO2 incubator. Then the blastocyst was washed three
times with the blastocyst medium, and the blastocyst was
transferred to a drop of guinea pig complement (Sigma)
diluted 1:5 with blastocyst medium for 30 min at 37°C in a
5% CO2 incubator. The blastocyst was washed again three
times with the blastocyst medium, and blebbing of the TE was
apparent. After the TE blebbing, if the TE was not completely
removed from the ICM, it was removed by passing the
blastocyst through a narrow pipette. The ICM was placed on
mouse embryonic fibroblasts ( M E F )a saf e e d e rl a y e rw i t h
HESC medium (Itskovitz-Eldor et al. 2000) supplemented
with 30 ng/ml of basic fibroblast growth factor (bFGF). The
medium was changed every 2 d, and after 5–12 d, when the
colony was around 300μm in diameter, it was cut (using a
filter-isolated mouth pipette) into two to three parts and
transferred to new plates. The new colonies were transferred
every 5–9 d, using mouth pipette, for the first few wk. At
passages 4–8, as the cell line is more established, we used
either trypsin/EDTA or collagenase type IV for transferring
the cells (Itskovitz-Eldor et al. 2000). Once the cell line was
established, we lowered the bFGF concentration to 5 ng/ml.
The CSES cell lines can be obtained from Cedars-Sinai
Medical Center for research purposes.
In vitro and in vivo differentiation of HESCs. Embryoid
bodies (EBs) were created as described previously (Itskovitz-
Eldor et al. 2000). EBs were generated by aggregation of the
HESCs for 10 d. For teratoma formation, 5×10
6 HESCs were
injected under the kidney capsule of 6–8-wk-old nude mice
(Robertson 1987). Each cell line was injected into two mice.
One month later, the mice were euthanized, and the teratomas
were removed. Part of the tissue was fixed by 10% buffered
formalin phosphate (Sigma), and RNAwas extracted from the
rest of the tissue as detailed below. The fixed tissues were
embedded in paraffin, and 4-μm sections were stained by
hematoxylin and eosin. Care of animals was in accordance
with institutional guidelines as approved by the Cedars-Sinai
310 K. NARWANI ET AL.Medical Center Institutional Animal Care and Use Commit-
tee, according to protocol #2182.
Staining for stem cell markers. For immunostaining, HESCs
were washed three times with PBS and fixed onto the plate
with 10% buffered formalin phosphate (Sigma). As primary
antibodies, we used mouse IgG anti-human OCT-3/4, mouse
IgM anti-human TRA-1-60 (Santa Cruz Biotechnology Inc,
Santa Cruz, CA) and rabbit anti-NANOG (Abcam Inc,
Cambridge, MA). As secondary antibodies, we used goat
anti-mouse IgG PE, goat anti-mouse IgM FITC, and donkey
anti-rabbit FITC (Santa Cruz Biotechnology Inc). The
primary antibody was incubated with the cells over night at
4°C. The next morning the cells were washed twice with
PBS and were incubated with the secondary antibody for
1 h, at room temperature. The cells were washed, and
nucleus staining was performed by incubation with 1 μg/ml
of bisBenzimide, Hoechst no 33258 (Sigma) for 10 min.
To analyze the alkaline phosphatase activity in the cells,
HESCs grown in a 12-well plate were fixed and labeled
with the alkaline phosphatase kit 86R-1KT (Sigma).
Fluorescence-activated cell sorter (FACS) analysis. Inorder
to analyze the cells by fluorescence-activated cell sorter
(FACS), the HESCs grown on MEFs were trypsinized and
resuspended in PBS/3% BSA. The primary antibody, either
mouse IgG anti-human SSEA4 or mouse IgM anti-human
TRA-1-60 (Santa Cruz Biotechnology Inc), was added, and
the cells were incubated on ice for 20 min. Then cells were
washed and incubated with the secondary antibody, either
goat anti-mouse IgG FITC or goat anti-mouse IgM FITC
(Santa Cruz Biotechnology Inc), on ice for 20 min in the
dark. The cells were washed and immediately analyzed by
FACS in a FACSCalibur system (Beckton Dickinson,
Franklin Lakes, NJ). Data analysis was performed using the
CELLQUEST software (Beckton Dickinson). Forward and
side scatter plots were used to exclude dead cells and debris
from the histogram analysis plots.
Gene expression by low-density arrays. RNA from undif-
ferentiated HESCs and from 10-d-old EBs was used for gene
expression studies using the TaqMan® Human Stem Cell
Pluripotency Array (ABI, Foster C i t y ,C A ) .G e n ee x p r e s s i o ni s
Figure 1. Undifferentiated
HESCs of the CSES lines
express alkaline phosphatase.
Elevated expression of the
enzyme alkaline phosphatase is
associated with undifferentiated
pluripotent stem cells. The
CSES lines exhibit typical
morphology of defined HESC
colonies of small undifferentiat-
ed cells on a MEF feeder layer,
and the colonies are positively
stained for alkaline phosphatase
(red). Scale bar is 100μm.
DERIVATION OF HESCS FROM PGS BLASTOCYSTS 311reported as DeltaCt values. For each individual gene, the
number of amplification cycles for the fluorescent reporter
signal to reach a common threshold value (Ct) was estimated,
and then normalized by subtracting the Ct value obtained for
t h es a m es a m p l ef o rap o s i t i v ec o n t r o lt r a n s c r i p t( b e t aa c t i n ) ,t o
give DeltaCt value.
Karyotype analysis. A 10-cm plate of HESCs in log growth
phase was used from each cell line. The night before the
procedure, the cells were fed with fresh 10 ml HESC media.
Next morning, KaryoMAX colcemid* (Invitrogen, Carlsbad,
CA) was added directly to the plate, to give a final
concentration of 100 ng/ml, and the cells were incubated
for 30 min at 37°C in a 5% CO2 incubator. Then cells were
trypsinized, treated with hypotonic solution, and fixed.
Metaphases were spread on microscope slides, and by using
standard G banding technique, the chromosomes were
classified according to the International System for Human
Cytogenetic Nomenclature (ISCN). At least 20 metaphases
were analyzed per cell line, and the final karyotype was
stated if at least 80% of the metaphases had it.
Analysis of the main ancestry components of the HESC
lines. DNA samples were extracted from the dozen HESC
lines, and their SNP profile was stated by Genechip Human
Mapping 500 K Array Set (Afffymetrix, Santa Clara, CA).
The main ancestry components of the different HESC
lines was characterized based on genome-wide average
proportion of alleles shared identical by state (IBS)
between any two samples. IBS was calculated using the
genotypes of 50,000 autosomal SNPs, randomly chosen
from the NspI Affymetrix GeneChip Mapping Array. We
analyzed the cell lines together with samples with known
ancestry (HapMap samples from northern and western
Europe, Japan, China and Africa). To visualize the
population genetic structure, we plotted the results of a
multidimensional scaling (MDS) analysis. The MDS
algorithm was used with the IBS matrix of pairwise
similarities, to assign a location to each sample in two-
dimensional space. Identical by descent (IBD) analysis
was used to identify relatedness between samples. Calcu-
lations of IBS and IBD and the MDS analysis were
performed using PLINK (Purcell et al. 2007).
Figure 2. Undifferentiated
HESCs of the CSES lines
express OCT4/NANOG.
Representative HESC colony
from each of the HESC lines is
positively stained for transcrip-
tion factor serving as markers of
undifferentiated HESCs:
POU5F1(OCT4) and NANOG.
These genes are closely
associated with the pluripotent
state of HESCs and are strongly
downregulated upon their
differentiation. Red or green
labeling for OCT4 (CSES1-7, 9,
and 14) and green labeling for
NANOG (CSES10 and 11).
Hoechst stain of nuclei of
HESCs and MEFs is in blue.
Scale bar is 100μm.
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In this report, we summarize the data that we have collected
from the derivation of a dozen HESC lines, carrying
euploid karyotypes. We started with fresh PGS-defined
aneuploid blastocyst-stage embryos carrying various chro-
mosomal abnormalities as trisomy of chromosomes 14, 15,
or 18 and monosomies of chromosomes 14, 16, 18, or 21.
As shown before, most of the embryos are mosaic, and the
in vitro culture conditions during the derivation of the
HESCs causes a strong selection for the euploid normal
cells (Lavon et al. 2008). The HESC lines derived from
these aneuploid embryos were karyotyped and found to
have euploid karyotype: nine female (46,XX) and three
male (46,XY). CSES14 was exceptional due to the fact that
on the top of the 46 chromosomes, it had in most of the
cells a translocation of segment from chromosome 17 to
chromosome 7 having a karyotype of 46XX,t(7;17).
In order to define the new cell lines as HESCs, we
needed to demonstrate that the cells express typical markers
of undifferentiated cells, have a self-renewal capacity, and
have the pluripotent ability to differentiate into derivatives
of the three embryonic germ layers. Elevated expression of
the enzyme alkaline phosphatase is associated with undif-
ferentiated pluripotent stem cells. In Fig. 1, we show that
the dozen HESC lines have alkaline phosphatase activity.
The HESCs show typical morphology of HESC colonies
grown on MEFs, and only the HESC colonies are positively
Table 1. FACS analysis of undifferentiated ES cells
FACS
%
CSES1
♀
CSES2
♀
CSES3
♀
CSES4
♂
CSES5
♀
CSES6
♀
CSES7
♀
CSES9
♂
CSES10
♀
CSES11
♀
CSES12
♂
CSES14
♀
SSEA4 85.4 82.6 86 79.4 86.6 84.35 83.6 84 78 91.7 93.4 95.8
TRA-1-60 78.2 78.4 83.8 82.3 90.6 88.68 86.6 87 84 91.1 92.0 94.4
Figure 3. Undifferentiated
HESCs of the CSES lines
express TRA-1-60. The keratan
sulfate antigen TRA-1-60 is
highly expressed in undifferen-
tiated HESCs. The dozen HESC
lines were analyzed by FACS,
and the cultures grown on MEFs
had 78–95% positive cells
(shown in Table 1). Presented
are HESC colonies from each
of the dozen HESC lines
stained for TRA-1-60.
Scale bar is 100μm.
DERIVATION OF HESCS FROM PGS BLASTOCYSTS 313stained. POU5F1(OCT4) and NANOG are regarded as
archetypal HESC markers (Adewumi et al. 2007). These
genes had been previously proposed as markers of
undifferentiated HESCs. They are closely associated with
the pluripotent state of HESCs and strongly downregulated
upon their differentiation. In Fig. 2, we show that the HESC
lines express these archetypal HESC markers, as revealed by
immunostaining with anti-OCT4 (CSES1-7, 9, and 14) and
anti-NANOG (CSES10 and 11) antibodies. By FACS, we
examined the expression of cell-surface antigens that are
widely used as markers of HESCs such as the glycolipid
SSEA4 and the keratan sulfate TRA-1-60 antigens. Table 1
details the results of the FACS analysis of the HESCs grown
on MEF with antibodies against TRA-1-60 and SSEA4; 78–
96% of the cells are positive for these HESCs surface
markers. The cells remained over 80% SSEA4 and TRA-1-
60 positive in low (P5-P15) and high passages (P25+) (data
not shown). We further tested the expression of the surface
marker, TRA-1-60, by immunostaining. In Fig. 3,w es h o w
that the HESC colonies are positively stained for TRA-1-60
in contrast to the MEF feeder layer. To examine cell
pluripotency, we tested their differentiation potential in vitro
and in vivo. In Fig. 4, we demonstrate the differentiation
potential of our different HESC lines upon in vivo
differentiation. All the HESC lines generated teratomas in
mice as shown by the sections of the teratomas stained with
hematoxylin and eosin. The teratomas are comprised of a
variety of cell structures and cell types. Among the structures
seen in the various teratomas are neural rosettes, gut-like
structures, fat tissue, and cartilage foci. In vitro, we have
created EBs from all the cell lines and tested their expression
profile upon differentiation. The differentiated cells showed
elevated expression levels of the genes serving as markers
for differentiation into ectoderm, mesoderm, endoderm, and
trophectoderm. In Fig. 5, we demonstrate the expression
profile of a representative cell line (CSES11) upon in vitro
differentiation. We observe upregulation in the expression of
these marker genes upon in vitro differentiation of the cells.
The average expression of each gene presented is higher in
the EBs compared to the undifferentiated cells. To further
characterize our HESCs, for each of the HESC lines, we
have analyzed its global SNP profile. This data allowed us to
Figure 4. Upon in vivo
differentiation, the CSES lines
generate teratomas. Upon in
vivo differentiation into
teratomas, the CSES cell lines
differentiate into a variety of
structures and comprised of
heterogeneous cell types; shown
are 4-μm sections of teratomas
stained with hematoxylin and
eosin. In all cell lines, we have
seen presentation of structures
from the three embryonic germ
layers. Shown are variety of
structures and cell types
including neural rosettes,
gut-like structures, cartilage,
connective tissue, adipose,
and muscle cells. Scale bar
is 100μm.
314 K. NARWANI ET AL.have the unique footprint of each HESC line. Moreover, the
data allowed us to explore the ethnic origin (the main
ancestry components) of the different HESC lines and
possible family relatedness among them. Figure 6 shows
the results of a multidimensional scaling analysis. Most lines
(eight out of 12) fall within (CSES2, CSES3, CSES9, and
CSES10) or very near (CSES1, CSES4, CSES5, CSES6, and
CSES14) the northern and western European cluster. The cell
lines falling near the western European cluster could be of
Eastern European or Ashkenazi Jewish ancestry (Price et al.
2008). The three lines falling far from the European cluster
include CSES12 that falls within the Chinese cluster (Fig. 6,
inset), and CSES7 and CSES11 that are spaced between the
European and the Asian clusters, suggesting a possible
admixture effect. IBD analysis identified high IBD level
between CSES5 and CSES6 (0.47) and between CSES9 and
CSES10 (0.46), suggesting that they are derived from the
same parents (“full sibs”). No other family relatedness was
found between the other cell lines.
Discussion
We have derived 12 new HESC lines from PGS-biopsied
embryos and have shown that they express markers of
undifferentiated cells, have a self-renewal capacity, and
have the pluripotent ability to differentiate into derivatives
of the three embryonic germ layers (Figs. 1, 2, 3, 4, and 5
and Table 1). To further characterize the HESCs, we stated
the main ancestry components of the different HESC lines
and possible family relatedness among them (Fig. 6).
The embryos that we used for the derivation of new HESC
lines were reported to have chromosomal aberrations by PGS.
These embryos were destined to be discarded. From these
embryos, we have derived HESC lines that were found to
carry a normal euploid karyotype. These HESC lines were
characterizedaspluripotentcellshavingself-renewalcapacity,
JAP & CHB
CEU
YRI
CSES12
CSES7
CSES11
JAP CHB
CSES12
Figure 6. The main ancestry components of the different HESC lines
and possible family relatedness among them. Shown are the results of
the MDS based on genotypes of the HESC lines (light gray circles)
together with HapMap samples (dark gray circles) from three different
populations. The MDS analysis on the HapMap samples separates out
threeclusterscorrespondingtoEuropean(northernandwesternEuropean
ancestry; CEU), Asian (Japan and China; JAP and CHB), and African
(Yoruba people of Ibadan, Nigeria; YRI) ancestry. The inset shows a
separate MDS analysis on Asian HapMap individuals and CSES12. The
two clusters correspond to JAP (right, light gray)a n dCHB (left, dark
gray). CSES12 (light gray diamond) falls within the CHB cluster.
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Figure 5. Upon in vitro differentiation, the CSES lines generate EBs
expressing the differentiation markers for ectoderm, mesoderm,
endoderm, and trophectoderm. Markers representing each of the germ
layers are presented in the graph; ectoderm (OLIG2, PAX6, and
ISL1), mesoderm (PECAM1, CDH5, and MYOD1), endoderm (SST,
PDX1, SERPINA1, and AFP), and trophectoderm (KRT1, CGB,
GCM1, and CDX2). The results presented are from the expression
data of CSES11. Each bar represents the average induction in the
expression of each gene upon differentiation into EBs. An increase in
the delta ct ES−delta ctEB value of 1 denotes a twofold increase in the
mRNA levels of this gene upon differentiation to EBs.
DERIVATION OF HESCS FROM PGS BLASTOCYSTS 315similar to HESC lines derived from embryos that were not
reported as aneuploid. These results led us to conclude that
these aneuploid embryos that were due to be discarded can
serveasa sourcefornormaleuploidHESClines.Inmostlabs,
the source for derivation of HESCs comes from frozen
embryos donated by families that have finished their
reproductive plan. This type of embryos is rarely donated in
certain populations that can afford to store the embryos for
very long period. On the other hand, the majority of the
couples that went through PGS donated their aneuploid
embryos for research. Thus, these PGS embryos serve as an
important source for deriving euploid HESCs.
We performed SNP analysis for each of the HESC lines, in
order to obtain a footprint of each line and to identify their
ethnic origin and family relatedness among them. Exploring
theethnicoriginofthedifferentHESClinesallowsustorefine
our analysis and address biological questions that are relevant
tospecificethnicgroups.Moreover,knowingtheethnicorigin
of the HESC lines will allow us to test whether there are
phenotypes that are common to HESC lines from a specific
ethnic origin or whether they are general for the whole
population. Our HESC lines are varied, most lines fall within
or very near the northern and western European cluster, one
fallswithintheChinesecluster,andtwoareamixturebetween
theEuropeanandtheAsianclusters.Currently,wedonothave
HESC lines from African (Yoruba) origin. Thus we believe
that there is a need to derive more HESC lines that will
represent more populations.
Two pairs of HESC lines had high levels of identity by
descent, suggesting that they are derived from the same
parents (“full sibs”). The sibling HESC lines are a valuable
resource for further investigating the effects of genetic
background on the growth characteristics, pluripotency, and
differentiation potential of the HESCs (Chen et al. 2009).
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